Folic acid therapy in the fragile X syndrome
- 作者W. T. Brown; E. C. Jenkins; E. Friedman; J. Brooks; I. L. Cohen; C. Duncan; A. L. Hill; M. N. Malik; V. Morris; E. Wolf; K. Wisniewski; J. H. French; John M. Opitz
- 卷第17卷
- 期第1期
- 印刷ISSN1552-4825
- 电子ISSN1552-4833
- 文件大小473.30KB
- 发表时间1984
- DOI10.1002/ajmg.1320170121
- 页码289-297
Excess thymidine induces folate sensitve fragile sitesGrant R. Sutherland; Elizabeth Baker; Antonio Fratini; John M. Opitz; James F. Reynolds · 1985
Fragile X transmission and the determination of carrier probabilities for genetic counsellingJohn C. Mulley; Grant R. Sutherland; John M. Opitz; James F. Reynolds · 1987
Effects of nucleotides on expression of the folate sensitive fragile sitesDr. Grant R. Sutherland; Elizabeth Baker; John M. Opitz; James F. Reynolds · 1986
Phenotypic variation in male-transmitted fragile X: Genetic inferencesDr. Danuta Z. Loesch; David A. Hay; Grant R. Sutherland; J. Halliday; C. Judge; G. C. Webb; John M. Opitz; James F. Reynolds · 1987
Linkage and genetic counselling for the fragile X using DNA probes 52A, F9, DX13, and ST14John C. Mulley; Agi K. Gedeon; Kerry A. Thorn; Lyndall J. Bates; Grant R. Sutherland; John M. Opitz; James F. Reynolds · 1987
Second international workshop on the fragile X and on X-linked mental retardationGillian Turner; John M. Opitz; W. Ted Brown; Kay E. Davies; Patricia A. Jacobs; Edmund C. Jenkins; Margareta Mikkelsen; Michael W. Partington; Grant R. Sutherland; James F. Reynolds · 1986
A fertile man with tdic(Y;22): How a stable neo-X1X2Y sex-determining mechanism could evolve in manDr. David F. Callen; Grant R. Sutherland; Rodney F. Carter; John M. Opitz; Jay Bernstein · 1987